News
Preliminary evidence indicates famotidine might improve COVID-19 symptoms
Apart from two cases of anosmia, symptoms resolved completely within 14 days of starting famotidine.
Article
Can an app guide cancer treatment decisions during the pandemic?
News
Three years of imatinib may halve death rate in GIST
Receiving imatinib for 3 years rather than 1 year improved overall survival by 50% and recurrence-free survival by 30%.
News
Virtual ADA Scientific Sessions to offer full program
Program features fewer blockbuster trials than in years past but plenty of meaty clinical material.
News
TKI plus SBRT tops TKI alone for oligometastatic EGFRm NSCLC
News
Cannabis misconceptions still common among MS clinicians
Studies and surveys underscore that misconceptions about cannabis could be common among clinicians and patients.
News
Today’s Top News Highlights: Your coding questions answered, biologics and melanoma, and more
“The likelihood that approximately 40%-45% of those infected with SARS-CoV-2 will remain asymptomatic suggests that the virus might have greater...
News
Doctors’ top telehealth coding questions answered
This column addresses several readers’ questions on using telehealth and provides guidance on delivering mental health services remotely.
Article
Prolonged azithromycin Tx for asthma?
In “Asthma: Newer Tx options mean more targeted therapy” (J Fam Pract. 2020;65:135-144), Rali et al recommend azithromycin as an add-on...
Article
Include a behavioral health specialist in ADHD evaluations
Unless these other problems are addressed, treatment focused only on ADHD often yields suboptimal results.